—HD
— • —
$337.34
P/E
23.70
PEG
—
FCF Yield
—
Rev Growth YoY
+324.0% YoY
Gross Margin
3332.0%
Health Score
4/10
D/E Ratio
4.35
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, which limits contextual framing. Based on the available financial data — including a current price of $337.34, a Price/Sales ratio of 2.04x, and extraordinarily high reported margins — this appears to be a financially active company with unusual reporting characteristics. Given the absence of a market cap figure, the cap tier cannot be confirmed, though the price point and valuation ratios suggest a mid-to-large-cap profile.
Financial Health
**Score: 4/10** The financial picture here is deeply contradictory. On the surface, a gross margin of 3,332% and a net margin of 860% appear extraordinary, but figures this far outside normal ranges are a significant red flag for data reliability or unusual one-time accounting events...
Risk Assessment
- **DEBT:** Debt/equity of 4.35x is highly leveraged and leaves limited financial flexibility in a rising-rate or revenue-shock environment. - **DATA RELIABILITY:** Gross margin of 3,332% and net margin of 860% are statistically implausible for nearly any industry; these figures may reflect accounting anomalies, data errors, or non-recurring events. - **EARNINGS DETERIORATION:** Earnings growth of -452.0% YoY despite strong revenue growth signals a severe profitability breakdown. - **CASH FLOW OPACITY:** Free cash flow is unavailable, making it impossible to verify whether reported profits translate to real liquidity. - **TECHNICAL WEAKNESS:** A confirmed death cross (50-day MA crossing below 200-day MA) and a bearish MACD signal indicate negative price momentum with price trading below both key moving averages. ---...